檢視任路瑶的原始碼

'''任路瑶'''
{| class="wikitable" style="float:right; margin: -10px 0px 10px 20px; text-align:left"
|<center>'''任路瑶'''<br><img src="https://hupi.fudan.edu.cn/__local/3/08/28/11F4AE7F7E660FE02A56EC4571B_1CECEDAF_17A3.jpg" width="280"></center><small>[https://www.fdsm.fudan.edu.cn/AboutUs/preview.html?uid=012018 圖片來自搜狗网]</small> 
|}
<ref>[https://www.gerenjianli.com/Mingren/Tags/6997/ 名人励志故事]</ref>
== 工作经历 ==
2012.9 - 2016.6，[[复旦大学]]，生物科学专业，[[学士]]

2016.9 - 2021.6，复旦大学，[[遗传学专业]]，[[博士]]
== 研究方向 ==

从组学标准物质研制、标准数据集构建、数据分析方法评估等方面进行深入研究，以确保组学数据质量和分析方法准确可靠，为[[肿瘤]]精准诊疗奠定基础。

== 获奖情况 ==

复旦大学优秀毕业生（2021）

== 代表论文 ==
1.Xiao W*#, Ren L*, Chen Z, Fang LT, Zhao Y, Lack J, Jaeger E, Kerrigan L, Blomquist T, Hung T, …, Wang C#, Shi L#. Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nature Biotechnology, 39(9):1141-1150 (2021)

2.Fang LT*, Zhu B*, Zhao Y*, Chen W, Yang Z, Kerrigan L, Langenbach K, Mars M, Lu C, Idler K, Jacob H, Zheng Y, Ren L, …, Hong H#, Shi L#, Wang C#, Xiao W#. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nature Biotechnology, 39(9):1151-1160 (2021)

3.Zheng Y*, Li B*, Pan D*, Cao J, Zhang J, Wang X, Li X, Hou W, Bao D, Ren L, Yang J, Wang S, Qiu Y, Zhou F, Liu Z, Zhu S, Zhang L, Qing T, Wang Y, Yu Y, Wu J#, Hu X#, Shi L#. Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer Patient. Breast Cancer Research, 23(1):53 (2021)

4.Jiang YZ*, Ma D*, Suo C*, Shi J*, Xue M, Hu X, Xiao Y, Yu KD, Liu YR, Yu Y, Zheng Y, Li X, Zhang C, Hu P, Zhang J, Hua Q, Zhang J, Hou W, Ren L, Bao D, …, Wang P#, Shi L#, Huang W#, Shao ZM#. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell, 35(3):428-440 (2019)

<ref>[https://www.diyifanwen.com/tool/ 名人名言]</ref>

==参考文献==
{{Reflist}}
[[Category:文化藝術人物]]

[[Category:人文社科藝術人物]]